Demant A/S (DEMANT) - Total Assets
Based on the latest financial reports, Demant A/S (DEMANT) holds total assets worth Dkr39.07 Billion DKK (≈ $6.11 Billion USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check Demant A/S cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Demant A/S - Total Assets Trend (2002–2025)
This chart illustrates how Demant A/S's total assets have evolved over time, based on quarterly financial data. Explore long-term investment intensity of Demant A/S to see how much of total assets are deployed in long-term investments.
Demant A/S - Asset Composition Analysis
Current Asset Composition (December 2025)
Demant A/S's total assets of Dkr39.07 Billion consist of 25.3% current assets and 74.7% non-current assets.
| Asset Category | Amount (DKK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Dkr0.00 | 3.4% |
| Accounts Receivable | Dkr4.66 Billion | 11.9% |
| Inventory | Dkr2.62 Billion | 6.7% |
| Property, Plant & Equipment | Dkr0.00 | 0.0% |
| Intangible Assets | Dkr1.34 Billion | 3.4% |
| Goodwill | Dkr19.03 Billion | 48.7% |
Asset Composition Trend (2002–2025)
This chart illustrates how Demant A/S's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Demant A/S.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Demant A/S's current assets represent 25.3% of total assets in 2025, a decrease from 73.9% in 2002.
- Cash Position: Cash and equivalents constituted 3.4% of total assets in 2025, down from 5.9% in 2002.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 51.0% of total assets, an increase from 0.0% in 2002.
- Asset Diversification: The largest asset category is goodwill at 48.7% of total assets.
Demant A/S Competitors by Total Assets
Key competitors of Demant A/S based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
COCHLEAR LTD ADR 1/2/O.N.
F:OC50
|
Germany | €2.83 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.89 Billion |
|
Novocure Ltd
NASDAQ:NVCR
|
USA | $787.93 Million |
|
Shanghai MicroPort EV MedTech Co. Ltd. A
SHG:688351
|
China | CN¥2.00 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.52 Billion |
|
Anteris Technologies Global Corp
AU:AVR
|
Australia | AU$19.07 Million |
|
Beijing Chunlizhengda Medical Instruments Co Ltd
SHG:688236
|
China | CN¥3.54 Billion |
|
Tellgen Corp
SHE:300642
|
China | CN¥2.01 Billion |
Demant A/S - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.33 | 1.63 | 0.91 |
| Quick Ratio | 0.98 | 1.22 | 0.64 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Dkr2.48 Billion | Dkr3.83 Billion | Dkr-687.00 Million |
Demant A/S - Advanced Valuation Insights
This section examines the relationship between Demant A/S's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.78 |
| Latest Market Cap to Assets Ratio | 0.21 |
| Asset Growth Rate (YoY) | 20.4% |
| Total Assets | Dkr39.07 Billion |
| Market Capitalization | $8.14 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Demant A/S's assets below their book value (0.21x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Demant A/S's assets grew by 20.4% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Demant A/S (2002–2025)
The table below shows the annual total assets of Demant A/S from 2002 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Dkr39.07 Billion ≈ $6.11 Billion |
+20.41% |
| 2024-12-31 | Dkr32.45 Billion ≈ $5.08 Billion |
+6.23% |
| 2023-12-31 | Dkr30.55 Billion ≈ $4.78 Billion |
+2.31% |
| 2022-12-31 | Dkr29.86 Billion ≈ $4.67 Billion |
+20.10% |
| 2021-12-31 | Dkr24.86 Billion ≈ $3.89 Billion |
+13.38% |
| 2020-12-31 | Dkr21.93 Billion ≈ $3.43 Billion |
+0.59% |
| 2019-12-31 | Dkr21.80 Billion ≈ $3.41 Billion |
+21.54% |
| 2018-12-31 | Dkr17.93 Billion ≈ $2.81 Billion |
+10.56% |
| 2017-12-31 | Dkr16.22 Billion ≈ $2.54 Billion |
+4.33% |
| 2016-12-31 | Dkr15.55 Billion ≈ $2.43 Billion |
+8.05% |
| 2015-12-31 | Dkr14.39 Billion ≈ $2.25 Billion |
+28.26% |
| 2014-12-31 | Dkr11.22 Billion ≈ $1.76 Billion |
+8.32% |
| 2013-12-31 | Dkr10.36 Billion ≈ $1.62 Billion |
+18.00% |
| 2012-12-31 | Dkr8.78 Billion ≈ $1.37 Billion |
+14.79% |
| 2011-12-31 | Dkr7.65 Billion ≈ $1.20 Billion |
+12.68% |
| 2010-12-31 | Dkr6.79 Billion ≈ $1.06 Billion |
+46.68% |
| 2009-12-31 | Dkr4.63 Billion ≈ $723.83 Million |
+17.83% |
| 2008-12-31 | Dkr3.93 Billion ≈ $614.30 Million |
+5.38% |
| 2007-12-31 | Dkr3.73 Billion ≈ $582.92 Million |
+18.86% |
| 2006-12-31 | Dkr3.13 Billion ≈ $490.42 Million |
+8.33% |
| 2005-12-31 | Dkr2.89 Billion ≈ $452.69 Million |
+18.54% |
| 2004-12-31 | Dkr2.44 Billion ≈ $381.90 Million |
+21.14% |
| 2003-12-31 | Dkr2.01 Billion ≈ $315.26 Million |
+1.18% |
| 2002-12-31 | Dkr1.99 Billion ≈ $311.59 Million |
-- |
About Demant A/S
Demant A/S operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. It engages in the development, manufacture, and wholesale of hearing aids; owning and operating hearing care clinics; and offers hearing and balance assessment solutions used by audiologists, ENT doctors, and balance clinics. The company was formerly known as William Demant Hol… Read more